T20, Enfuvirtide - 1 mg
- Cat.Number : AS-61235
- Manufacturer Ref. :
-
Availability :
In stock
This 36-residue synthetic peptide strongly inhibits HIV-1 viral fusion with CD4 cells with an EC50 of 1 ng/ml.
It is a peptide mimetic of an essential region within the viral envelope glycoprotein gp41 that functions by blocking gp41 structural rearrangements at a transitional pre-fusion conformation.
Specifications
| Chemistry | |
| Sequence one letter code |
|
|---|---|
| Sequence three letter code |
|
| CAS registry number |
|
| Molecular Formula |
|
| Molecular Mass/ Weight |
|
| Modification | |
| Conjugation |
|
| Quantity & Purity | |
| Purity |
|
| Storage & stability | |
| Form |
|
| Storage Conditions |
|
| Activity | |
| Biomarker Target | |
| Research Area | |
| Sub-category Research Area | |
| Usage |
|
| Source | |
| Source / Species |
|
Downloads
You may also be interested in the following product(s)
Citations
Phosphorylation of HIV Nef by cAMP-dependent protein kinase
Virology. . 2005 Jan 20 ; 331(2) 367 | DOI : 10.1016/j.virol.2004.11.004
- PL. Lia
References
T20/DP178, an Ectodomain Peptide of Human Immunodeficiency Virus Type 1 gp41, Is an Activator of Human Phagocyte N-Formyl Peptide Receptor
Blood . 1990 Jan 22 ; 93(11) 3885 | DOI : https://doi.org/10.1182/blood.V93.11.3885
- SB. Su
- et al
HIV-1 Membrane Fusion Mechanism: Structural Studies of the Interactions between Biologically-Active Peptides from gp41
Biochem . 1996 Oct 22 ; 35(42) 13697 | DOI : https://doi.org/10.1021/bi9606962
- MK. Lawless
- et al